Drug Utilization Review Board
Meeting Agenda
Thursday, February 13, 2025
7:15 a.m to 8:30 a.m
Google Meet joining info
Video call link: meet.google.com/zue-rrqz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306 #
Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov prior to the meeting or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints.
1) Call to order - Luis Moreno, PharmD
a) Welcome and Introductions - Luis Moreno, PharmD - Housekeeping
b) Review and Approval of Minutes
2) P&T Update - Ngan Huynh, PharmD
3) Review
a) Presentation: CAR-T Therapies for Large B-cell Lymphoma and Acute Lymphoblastic Leukemia - Monet Luloh, PharmD
i) Public Comment
(1) Bristol Myers Squibb-Abecma - Keith Huff, PharmD
(2) Johnson & Johnson-Carvykti - Amy Hale, PharmD
b) Abecma (idecabtagene vicleucel) Prior Authorization - Kyu Yun Park, Pharm D
i) Committee Discussion/Questions
c) Carvykti (idecabtagene vicleucel) Prior Authorization - Kyu Yun Park, PharmD
i) Committee Discussion/Questions
d) Yescarta (axicabtagene ciloleucel) Prior Authorization - Ngan Huynh, PharmD
i) Committee Discussion/Questions
e) Lenmeldy (atidarsagene autotemcel) Prior Authorization .Ngan Huynh, PharmD
i) Committee Discussion/Questions
4) Next Meeting
a) March 13, 2025 - Aucatzyl, Breyanzi, Kymriah, Tecartus Prior Authorization Review
5) Adjourned
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should contact Luis Moreno at lmoreno@utah.gov or (801) 538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/zue-rrqz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306 #